Franklin Resources
CLVS

Franklin Resources’s Clovis Oncology, Inc. CLVS Stock Holding History

Franklin Resources’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,761,885
Closed -$51.7M – 1543
2018
Q3 		$51.7M Sell
1,761,885
-494,638
-22% -$19.2M 0.03% 527
2018
Q2 		$103M Sell
2,256,523
-233,016
-9% -$11.3M 0.05% 356
2018
Q1 		$131M Sell
2,489,539
-144,862
-5% -$8.45M 0.07% 299
2017
Q4 		$179M Buy
2,634,401
+318,931
+14% +$22.3M 0.09% 246
2017
Q3 		$191M Buy
2,315,470
+650,270
+39% +$51.6M 0.09% 237
2017
Q2 		$156M Buy
1,665,200
+687,300
+70% +$42.1M 0.08% 261
2017
Q1 		$62.3M Buy
977,900
+412,000
+73% +$25M 0.03% 466
2016
Q4 		$25.1M Buy
565,900
+50,300
+10% +$1.77M 0.01% 728
2016
Q3 		$18.6M Buy
+515,600
New +$11.1M 0.01% 828
2014
Q3 		– Sell
-465,198
Closed -$19.3M – 1599
2014
Q2 		$19.3M Sell
465,198
-164,202
-26% -$8.46M 0.01% 881
2014
Q1 		$43.6M Buy
629,400
+119,600
+23% +$8.78M 0.02% 624
2013
Q4 		$30.7M Buy
509,800
+189,400
+59% +$10.3M 0.02% 694
2013
Q3 		$19.5M Buy
320,400
+1,500
+0.5% +$106K 0.01% 813
2013
Q2 		$21.4M Buy
+318,900
New +$14.3M 0.01% 736

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Franklin Resources's CLVS Position: Q4 2018 in Review

Franklin Resources sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 1,761,885 shares — an estimated $51.7M sold.

Franklin Resources first reported a position in CLVS in Q2 2013 and held it in 14 quarters. The position peaked at $191M in Q3 2017. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Franklin Resources reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Franklin Resources sold 1,761,885 Clovis Oncology, Inc. shares in Q4 2018, an estimated $51.7M.
  • Franklin Resources first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 14 quarters.
  • Franklin Resources's Clovis Oncology, Inc. position peaked at $191M in Q3 2017.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Franklin Resources's 13F filing for Q4 2018, filed 12 Feb 2019.